Literature DB >> 22764419

Optimized preparation of celastrol-loaded polymeric nanomicelles using rotatable central composite design and response surface methodology.

Xia Peng1, Juan Wang, Hua Song, Daxiang Cui, Li Li, Jia Li, Lihui Lin, Juan Zhou, Yanan Liu.   

Abstract

Celastrol has been found to be a potent anti-inflammatory and antitumor plant derivative recently. Herein we established an accurate reverse phase HPLC (RP-HPLC) determination method of celastrol, and prepared an effective nanoscale drug delivery system from the optimized formulations of celastrol-loaded carboxyl functioned poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)(PEO-block-PPO-block-PEO, Pluronic) polymeric nanomicelles. Rotatable central composite design (RCCD) and response surface methodology (RSM) were applied to improve the celastrol entrapment efficiency (EE), drug loading percentage (DLP), and decrease the particle size. The characteristics of the optimized micelles including particle size distribution, morphology, zeta potential and in vitro release of celastrol from micelles were carried out. Results showed that RP-HPLC method was successfully applied to detect and qualify the celastrol. The drug quantification range of the method was 20-200 microg/mL with a linear correlation coefficient of greater than 0.999. The average accuracy (99.763%), the precision (0.521%) and recovery (99.63%) for this method were good. The optimal conditions for the preparation of celastrol-loaded polymeric nanomicelles were found to be: the celastrol/polymer weight ratio 8.5-9 mg/25 mg, hydration volume 11-17 mL. Under the optimal conditions, the EE was 100.3 +/- 4.3%, DLP was 22.8 +/- 1.0%, the average particle size was 117.3 +/- 1.27 nm and the zeta potential was -2.19 +/- 0.15 mV. Transmission electron micrograph (TEM) showed the micelles to be oval and rodlike shaped, with mean diameter around 20 nm. The in vitro experiments proved that celastrol in polymeric nanomicelles released gradually over the period of 24 h. These results showed that the RCCD and RSM could efficiently be applied for optimized preparation of celastrol-loaded polymeric nanomicelles.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22764419     DOI: 10.1166/jbn.2012.1398

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  4 in total

Review 1.  Celastrol: A Spectrum of Treatment Opportunities in Chronic Diseases.

Authors:  Rita Cascão; João E Fonseca; Luis F Moita
Journal:  Front Med (Lausanne)       Date:  2017-06-15

2.  Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CLpro of COVID-19 and Acts as Superoxide Radical Scavenger.

Authors:  Francesco Caruso; Manrose Singh; Stuart Belli; Molly Berinato; Miriam Rossi
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

3.  Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer.

Authors:  Xiaohu Zeng; Xin Zhu; Qikang Tian; Xiaoke Tan; Ning Sun; Min Yan; Junwei Zhao; Xiangxiang Wu; Ruiqin Li; Zhenqiang Zhang; Huahui Zeng
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

4.  Oral Bioavailability Evaluation of Celastrol-Encapsulated Silk Fibroin Nanoparticles Using an Optimized LC-MS/MS Method.

Authors:  Shuyu Zhan; Amy Paik; Felicia Onyeabor; Baoyue Ding; Sunil Prabhu; Jeffrey Wang
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.